1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
Blanco, F.J.
Ortiz, A.R.
Serrano, L.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
1
90.00
90.00
90.00
1.000
1.000
1.000
C3 H7 N O2
89.093
y
ALANINE
L-peptide linking
C6 H15 N4 O2 1
175.209
y
ARGININE
L-peptide linking
C4 H8 N2 O3
132.118
y
ASPARAGINE
L-peptide linking
C4 H7 N O4
133.103
y
ASPARTIC ACID
L-peptide linking
C5 H10 N2 O3
146.144
y
GLUTAMINE
L-peptide linking
C5 H9 N O4
147.129
y
GLUTAMIC ACID
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H13 N O2
131.173
y
ISOLEUCINE
L-peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C6 H15 N2 O2 1
147.195
y
LYSINE
L-peptide linking
C5 H11 N O2 S
149.211
y
METHIONINE
L-peptide linking
C9 H11 N O2
165.189
y
PHENYLALANINE
L-peptide linking
C5 H9 N O2
115.130
y
PROLINE
L-peptide linking
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
C4 H9 N O3
119.119
y
THREONINE
L-peptide linking
C11 H12 N2 O2
204.225
y
TRYPTOPHAN
L-peptide linking
C9 H11 N O3
181.189
y
TYROSINE
L-peptide linking
C5 H11 N O2
117.146
y
VALINE
L-peptide linking
NE
J.Biomol.NMR
JBNME9
0800
0925-2738
9
347
357
10.1023/A:1018330122908
9255941
1H and 15N NMR assignment and solution structure of the SH3 domain of spectrin: comparison of unrefined and refined structure sets with the crystal structure.
1997
US
Nat.Struct.Biol.
NSBIEW
2024
1072-8368
3
874
Different Folding Transition States May Result in the Same Native Structure
1996
UK
Nature
NATUAS
0006
0028-0836
359
851
Crystal Structure of a Src-Homology 3 (SH3) Domain
1992
10.2210/pdb1aey/pdb
pdb_00001aey
1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
7229.244
ALPHA-SPECTRIN
SRC HOMOLOGY 3 DOMAIN
1
man
polymer
no
no
MDETGKELVLALYDYQEKSPREVTMKKGDILTLLNSTNKDWWKVEVNDRQGFVPAAYVKKLD
MDETGKELVLALYDYQEKSPREVTMKKGDILTLLNSTNKDWWKVEVNDRQGFVPAAYVKKLD
A
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
chicken
sample
CYTOSKELETON
9031
BRAIN
Gallus gallus
469008
Escherichia coli
BL21(DE3)
plasmid
PET3D
database_2
pdbx_database_status
pdbx_nmr_software
pdbx_struct_assembly
pdbx_struct_oper_list
repository
Initial release
Version format compliance
Version format compliance
Data collection
Database references
Derived calculations
Other
1
0
1997-05-15
1
1
2008-03-26
1
2
2011-07-13
1
3
2022-02-16
_database_2.pdbx_DOI
_database_2.pdbx_database_accession
_pdbx_database_status.process_site
_pdbx_nmr_software.name
Y
BNL
1997-03-02
REL
15
15
NOESY
TOCSY
COSY
HMQC-TOCSY
HMQC-NOESY
E.COSY
3.5
297
K
THE FINAL MODELS WERE ENERGY MINIMIZED IN A SHELL OF WATER MOLECULES USING THE AMBER ALL ATOM FORCE FIELD.
VARIABLE TARGET FUNCTION SIMULATED ANNEALING
PEARLMAN,CASE,CALDWELL,ROSS,CHEATHAM, FERGUSON,SEIBEL,SINGH,WEINER,KOLLMAN
refinement
Amber
4.1
structure solution
UXNMR
structure solution
AURELIA
structure solution
DIANA
structure solution
Amber
500
Bruker
AMX500
n
1
1
A
n
2
2
A
n
3
3
A
n
4
4
A
GLY
5
n
5
GLY
5
A
LYS
6
n
6
LYS
6
A
GLU
7
n
7
GLU
7
A
LEU
8
n
8
LEU
8
A
VAL
9
n
9
VAL
9
A
LEU
10
n
10
LEU
10
A
ALA
11
n
11
ALA
11
A
LEU
12
n
12
LEU
12
A
TYR
13
n
13
TYR
13
A
ASP
14
n
14
ASP
14
A
TYR
15
n
15
TYR
15
A
GLN
16
n
16
GLN
16
A
GLU
17
n
17
GLU
17
A
LYS
18
n
18
LYS
18
A
SER
19
n
19
SER
19
A
PRO
20
n
20
PRO
20
A
ARG
21
n
21
ARG
21
A
GLU
22
n
22
GLU
22
A
VAL
23
n
23
VAL
23
A
THR
24
n
24
THR
24
A
MET
25
n
25
MET
25
A
LYS
26
n
26
LYS
26
A
LYS
27
n
27
LYS
27
A
GLY
28
n
28
GLY
28
A
ASP
29
n
29
ASP
29
A
ILE
30
n
30
ILE
30
A
LEU
31
n
31
LEU
31
A
THR
32
n
32
THR
32
A
LEU
33
n
33
LEU
33
A
LEU
34
n
34
LEU
34
A
ASN
35
n
35
ASN
35
A
SER
36
n
36
SER
36
A
THR
37
n
37
THR
37
A
ASN
38
n
38
ASN
38
A
LYS
39
n
39
LYS
39
A
ASP
40
n
40
ASP
40
A
TRP
41
n
41
TRP
41
A
TRP
42
n
42
TRP
42
A
LYS
43
n
43
LYS
43
A
VAL
44
n
44
VAL
44
A
GLU
45
n
45
GLU
45
A
VAL
46
n
46
VAL
46
A
ASN
47
n
47
ASN
47
A
ASP
48
n
48
ASP
48
A
ARG
49
n
49
ARG
49
A
GLN
50
n
50
GLN
50
A
GLY
51
n
51
GLY
51
A
PHE
52
n
52
PHE
52
A
VAL
53
n
53
VAL
53
A
PRO
54
n
54
PRO
54
A
ALA
55
n
55
ALA
55
A
ALA
56
n
56
ALA
56
A
TYR
57
n
57
TYR
57
A
VAL
58
n
58
VAL
58
A
LYS
59
n
59
LYS
59
A
LYS
60
n
60
LYS
60
A
LEU
61
n
61
LEU
61
A
ASP
62
n
62
ASP
62
A
author_defined_assembly
1
monomeric
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
x,y,z
identity operation
0.0000000000
0.0000000000
0.0000000000
A
O
LYS
59
A
O
LYS
59
A
N
LEU
10
A
N
LEU
10
A
O
GLU
7
A
O
GLU
7
A
N
LEU
33
A
N
LEU
33
A
O
THR
32
A
O
THR
32
A
N
GLU
45
A
N
GLU
45
A
O
TRP
42
A
O
TRP
42
A
N
VAL
53
A
N
VAL
53
1
A
MET
1
A
MET
1
1
Y
1
A
ASP
2
A
ASP
2
1
Y
1
A
GLU
3
A
GLU
3
1
Y
1
A
THR
4
A
THR
4
1
Y
2
A
MET
1
A
MET
1
1
Y
2
A
ASP
2
A
ASP
2
1
Y
2
A
GLU
3
A
GLU
3
1
Y
2
A
THR
4
A
THR
4
1
Y
3
A
MET
1
A
MET
1
1
Y
3
A
ASP
2
A
ASP
2
1
Y
3
A
GLU
3
A
GLU
3
1
Y
3
A
THR
4
A
THR
4
1
Y
4
A
MET
1
A
MET
1
1
Y
4
A
ASP
2
A
ASP
2
1
Y
4
A
GLU
3
A
GLU
3
1
Y
4
A
THR
4
A
THR
4
1
Y
5
A
MET
1
A
MET
1
1
Y
5
A
ASP
2
A
ASP
2
1
Y
5
A
GLU
3
A
GLU
3
1
Y
5
A
THR
4
A
THR
4
1
Y
6
A
MET
1
A
MET
1
1
Y
6
A
ASP
2
A
ASP
2
1
Y
6
A
GLU
3
A
GLU
3
1
Y
6
A
THR
4
A
THR
4
1
Y
7
A
MET
1
A
MET
1
1
Y
7
A
ASP
2
A
ASP
2
1
Y
7
A
GLU
3
A
GLU
3
1
Y
7
A
THR
4
A
THR
4
1
Y
8
A
MET
1
A
MET
1
1
Y
8
A
ASP
2
A
ASP
2
1
Y
8
A
GLU
3
A
GLU
3
1
Y
8
A
THR
4
A
THR
4
1
Y
9
A
MET
1
A
MET
1
1
Y
9
A
ASP
2
A
ASP
2
1
Y
9
A
GLU
3
A
GLU
3
1
Y
9
A
THR
4
A
THR
4
1
Y
10
A
MET
1
A
MET
1
1
Y
10
A
ASP
2
A
ASP
2
1
Y
10
A
GLU
3
A
GLU
3
1
Y
10
A
THR
4
A
THR
4
1
Y
11
A
MET
1
A
MET
1
1
Y
11
A
ASP
2
A
ASP
2
1
Y
11
A
GLU
3
A
GLU
3
1
Y
11
A
THR
4
A
THR
4
1
Y
12
A
MET
1
A
MET
1
1
Y
12
A
ASP
2
A
ASP
2
1
Y
12
A
GLU
3
A
GLU
3
1
Y
12
A
THR
4
A
THR
4
1
Y
13
A
MET
1
A
MET
1
1
Y
13
A
ASP
2
A
ASP
2
1
Y
13
A
GLU
3
A
GLU
3
1
Y
13
A
THR
4
A
THR
4
1
Y
14
A
MET
1
A
MET
1
1
Y
14
A
ASP
2
A
ASP
2
1
Y
14
A
GLU
3
A
GLU
3
1
Y
14
A
THR
4
A
THR
4
1
Y
15
A
MET
1
A
MET
1
1
Y
15
A
ASP
2
A
ASP
2
1
Y
15
A
GLU
3
A
GLU
3
1
Y
15
A
THR
4
A
THR
4
1
Y
2
A
TYR
13
0.062
SIDE CHAIN
2
A
TYR
15
0.090
SIDE CHAIN
2
A
ARG
21
0.101
SIDE CHAIN
3
A
ARG
21
0.107
SIDE CHAIN
3
A
ARG
49
0.076
SIDE CHAIN
4
A
TYR
13
0.091
SIDE CHAIN
5
A
TYR
15
0.067
SIDE CHAIN
5
A
ARG
21
0.114
SIDE CHAIN
7
A
TYR
13
0.065
SIDE CHAIN
7
A
TYR
15
0.079
SIDE CHAIN
9
A
TYR
13
0.070
SIDE CHAIN
10
A
TYR
13
0.073
SIDE CHAIN
11
A
TYR
13
0.075
SIDE CHAIN
12
A
TYR
15
0.093
SIDE CHAIN
12
A
ARG
21
0.094
SIDE CHAIN
12
A
ARG
49
0.103
SIDE CHAIN
14
A
TYR
15
0.109
SIDE CHAIN
15
A
TYR
15
0.071
SIDE CHAIN
15
-12.79
2.00
110.40
97.61
A
A
A
CB
CA
C
ASP
ASP
ASP
48
48
48
N
15
-11.80
1.80
110.60
98.80
A
A
A
N
CA
CB
ARG
ARG
ARG
49
49
49
N
1
A
LYS
6
-76.87
-142.17
1
A
LYS
39
75.25
-51.00
1
A
ASN
47
60.12
-72.85
1
A
ASP
48
-150.93
11.59
2
A
LYS
6
-70.92
-125.94
2
A
LEU
34
-98.11
-66.53
2
A
ASP
40
-130.22
-53.13
2
A
ASN
47
65.11
-80.81
3
A
LYS
6
-109.75
-153.49
3
A
SER
36
-84.30
49.44
3
A
ASN
47
61.46
-77.93
4
A
GLU
17
-47.14
152.08
4
A
ASP
40
-107.74
-65.35
4
A
ASN
47
63.93
-76.46
5
A
SER
36
-116.61
53.12
5
A
ASN
47
65.70
-86.56
6
A
LYS
6
58.68
95.34
6
A
SER
36
-109.41
43.82
6
A
THR
37
-88.73
37.76
6
A
ASN
47
62.98
-74.34
6
A
ASP
48
-160.18
22.34
7
A
LYS
6
-104.67
-152.99
7
A
ASN
47
67.49
-71.25
8
A
LYS
6
-81.93
-140.14
8
A
ASP
40
-152.86
-61.13
8
A
ASN
47
67.07
-69.08
8
A
ASP
48
-154.04
15.27
9
A
THR
37
-61.43
1.69
9
A
LYS
39
72.61
-59.89
9
A
ASP
40
-90.43
-64.27
9
A
ASN
47
61.28
-85.53
10
A
LYS
6
59.66
95.73
10
A
GLU
17
-39.63
132.67
10
A
ASN
47
58.18
-88.71
10
A
LEU
61
-93.37
38.77
11
A
ASN
47
67.05
-74.99
12
A
ASN
47
71.36
-63.16
12
A
ASP
48
-153.35
-1.45
12
A
GLN
50
-101.10
76.92
13
A
LEU
34
-146.37
-32.60
13
A
ASP
40
-159.17
-52.05
13
A
ASN
47
58.52
-77.11
13
A
LEU
61
-96.58
42.25
14
A
LYS
6
-158.07
48.25
14
A
LEU
34
-79.89
-72.24
14
A
ASN
47
64.79
-71.49
14
A
ASP
48
-156.38
22.55
15
A
LYS
6
-95.02
58.96
15
A
LEU
34
-145.48
-48.89
15
A
SER
36
-141.58
25.92
15
A
ASP
40
-95.47
-63.47
refinement
AMBER
ALPHA-SPECTRIN SRC HOMOLOGY 3 DOMAIN, SOLUTION NMR, 15 STRUCTURES
1
Y
N
A
ALA
55
A
ALA
55
HELX_P
A
TYR
57
A
TYR
57
5
1
3
CYTOSKELETON
CYTOSKELETON, CAPPING PROTEIN, CALCIUM-BINDING, DUPLICATION, SH3 DOMAIN
SPTA2_CHICK
UNP
1
1
P07751
MDPSGVKVLETAEDIQERRQQVLDRYHRFKELSSLRRQKLEDSYRFQFFQRDADELGKWIQEKLQIASDENYKDPSNLQG
KLQKHQAFEAEVQANSGAIVKLDETGNQMINEGHFASETIRTRLQELHRLWELLLEKMREKGVKLLQAQKLVQFLRECED
VMDWINDKEAIVTSEELGQDLEHVEVLQKKFEEFQTDLAAHEERVNEVNQFAGKLIQEQHPEEELIKSKQDEVNASWQRL
KGLAQQRQGKLFGAAEVQRFNRDVDETISWIKEKGQLMASDDFGRDLASVQALLRKHEGLERDLAAFHHKVKALCAEADR
LQQSHPINASQIQVKREELIANWEQIRTLAAERHARLNDSYRLQRFLADFRDLTSWVTEMKALINADELANDVAGAEALL
DRHQEHKGEIDAHEDSFRSADESGQALLAAGHYASDEVKEKLTILSDERSALLELWELRRQQYEQCMDLQLFYRDTEQVD
NWMSKQEAFLLNEDLGDSLDSVEALLKKHEDFEKSLSAQEEKITALDEFATKLIQNNHYAMDDVATRRDALLSRRNALHE
RAMKRRAQLADSFHLQQFFRDSDELKSWVNEKMKTATDEAYKDPSNLQGKVQKHQAFEAELSANQSRIDALEKAGQKLID
VNHYASDEVAARMNEVISLWKKLLEATELKGIKLREANQQQQFNRNVEDIELWLYEVEGHLASDDYGKDLTSVQNLQKKH
ALLEADVAAHQDPIDGITIQARQFQDAGHFDADNIKKKQEALVARYEALKDPMVARKQKLADSLRLQQLFRDIEDEETWI
REKEPIAASTNRGKDLIGVQNLLKKHQALQAEIAGHEPRIKAVTQKGNAMVEEGHFAAEDVKIKLNELNQKWDSLKAKAS
QRRQDLEDSLQAQQYFADANEAQSWMREKEPIVGSTDYGKDEDSAEALLKKHEALMSDLSAYGSSIQALREQAQSCRQQV
APTDDETGKELVLALYDYQEKSPREVTMKKGDILTLLNSTNKDWWKVEVNDRQGFVPAAYVKKLDPAQSASRENLLEEQG
SIALRQEQIDNQTLITKEVGSVSLRMKQVEELYHSLLELGEKRKGMLEKSCKKFMLFREANELQQWINEKEAALTNEEVG
ADLEQVEVLQKKFDDFQKDLKANESRLKDINKVANDLESEGLMAEEVQAVEHQEVYGMMPRDETDSKTVSPWKSARMMVH
TVATFNSIKELNERWRSLQQLAEERSQLLGSADEVQRFHRDADETKEWIEEKNQALNTDNYGHDLASVQALQRNDEGFER
DLAALGDKVNSLGETAQRLIQSHPELAEDLQEKCTELNQAWSSLGKRADQRKEKLGDSHDLQRFLSDFRDLMSWINGIRG
LVSSDELAKDVTGAEALLERHQEHRTEIDARAGTFQAFEQFGQQLLARGHYASPEIKEKLDILDQERTDLEKAWVQRRMM
LDQCLELQLFHRDCEQAENWMAAREAFLNTEDKGDSLDSVEALIKKHEDFDKAINVQEEKIAVLQSFADQLIAADHYAKG
VIANRRNEVLDRWRRLKAQMIEKRSKLGESQTLQQFSRDVDEIEAWISEKLQTASDESYKDPTNIQLSKLLSKHQKHQAF
EAELHANADRIRGVIEMGNPLIERGACAGSEDAVKARLAALADQWEFLVQKSSEKSQKLKEANKQQNFNTGIKDFDFWLS
EVEALLASEDYGKDLASVNNLLKKHQLLEADISAHEDRLKDLNSQADSLMTSSAFDTSQVKDKRETINGRFQRIKSMAAA
RRAKLNESHRLHQFFRDMDDEESWIKEKKLLVSSEDYGRDLTGVQNLRKKHKRLEAELAAHEPAIQGVLDTGKKLSDDNT
IGKEEIQQRLAQFVDHWKELKQLAAARGQRLEESLEYQQFVANVEEEEAWINEKMTLVASEDYGDTLAAIQGLLKKHEAF
ETDFTVHKDRVNDVCANGEDLIKKNNHHVENITAKMKGLKGKVSDLEKAAAQRKAKLDENSAFLQFNWKADVVESWIGEK
ENSLKTDDYGRDLSSVQTLLTKQETFDAGLQAFQQEGIANITALKDQLLAAKHIQSKAIEVRHASLMKRWNQLLANSAAR
KKKLLEAQEHFRKVEDLFLTFAKKASAFNSWFENAEEDLTDPVRCNSLEEIKALREAHDAFRSSLSSAQADFNQLAELDR
QIKSFRVASNPYTWFTMEALEETWRNLQKIIKERELELQKEQRRQEENDKLRQEFAQHANAFHQWIQETRTYLLDGSCMV
EESGTLESQLEATKRKHQEIRAMRSQLKKIEDLGAAMEEALILDNKYTEHSTVGLAQQWDQLDQLGMRMQHNLEQQIQAR
NTTGVTEEALKEFSMMFKHFDKDKSGRLNHQEFKSCLRSLGYDLPMVEEGEPDPEFESILDTVDPNRDGHVSLQEYMAFM
ISRETENVKSSEEIESAFRALSSERKPYVTKEELYQNLTREQADYCISHMKPYMDGKGRELPSAYDYIEFTRSLFVN
965
1025
1AEY
2
62
P07751
A
1
2
62
5
anti-parallel
anti-parallel
anti-parallel
anti-parallel
A
VAL
58
A
VAL
58
A
ASP
62
A
ASP
62
A
GLU
7
A
GLU
7
A
ALA
11
A
ALA
11
A
ILE
30
A
ILE
30
A
ASN
35
A
ASN
35
A
TRP
41
A
TRP
41
A
VAL
46
A
VAL
46
A
ARG
49
A
ARG
49
A
PRO
54
A
PRO
54
1
P 1